Jack Robinson

Mr. Robinson joined CD&R in 2015 and is principally engaged in evaluating investment opportunities. He has played a key role in the Firm’s investment in Covetrus, Cynosure, and Vera Whole Health, as he did in prior investments in naviHealth and TRANZACT. Prior to joining CD&R, he worked in the mergers and acquisitions group at Blackstone. Mr. Robinson has an M.B.A. from The Wharton School of the University of Pennsylvania and a B.S. in economics and engineering from the University of Pennsylvania.